RABMAX-D is a reliable combination tablet of Rabeprazole Sodium, a powerful proton pump inhibitor (PPI), and Domperidone, a prokinetic and antiemetic agent. This dual-action therapy is highly effective in the treatment of acidity, gas, GERD, nausea, and bloating.
-
Rabeprazole Sodium (EC) suppresses excess acid production in the stomach, promoting healing of gastric ulcers and protecting the mucosal lining.
-
Domperidone enhances gastrointestinal motility, helps prevent reflux, and relieves symptoms like belching, fullness, and nausea.
This formulation is ideal for patients dealing with reflux esophagitis, gastritis, or post-meal indigestion, offering rapid and long-lasting symptom relief.
Check out our complete range of digestion-related therapies in the tablet product category.
Key Benefits:
-
Dual relief from acidity and delayed gastric emptying
-
Reduces heartburn, bloating, and nausea
-
Enhances gastric motility and digestion
-
Suitable for short-term and maintenance use
-
Well-tolerated with minimal side effects
Indications:
-
Gastroesophageal Reflux Disease (GERD)
-
Acid peptic disorders
-
Functional dyspepsia and bloating
-
Gastritis and upper abdominal discomfort
-
Nausea and vomiting related to acid reflux
Dosage:
One tablet daily, preferably 15–30 minutes before meals, or as directed by a physician.
Packaging:
Alu-Alu Strip – 10×10 Tablets
Storage:
Store below 25°C in a cool, dry place. Keep away from direct sunlight and moisture.
⚠️ Caution & Safety Information:
-
To be used under medical supervision
-
Not recommended during pregnancy or lactation without doctor’s advice
-
Use with caution in patients with liver or kidney disorders
-
May cause mild side effects such as dry mouth, headache, or dizziness
-
Avoid use in patients with cardiac arrhythmia or known QT prolongation
-
Do not crush or chew the tablet—swallow whole
-
Keep out of reach of children
Availability:
RABMAX-D Tablets are available for PCD Pharma Franchise, bulk orders, and custom private branding. Max Pharma provides attractive packaging, product literature, and marketing inputs in the gastroenterology segment.
Reviews
There are no reviews yet.